v-SNARE Ykt6p inhibitors belong to a specific chemical class that plays a pivotal role in regulating intracellular vesicle trafficking within eukaryotic cells. These inhibitors are designed to target the Ykt6p protein, which is a member of the vesicle soluble N-ethylmaleimide-sensitive factor attachment protein receptor (v-SNARE) family. The v-SNAREs, including Ykt6p, are crucial components of the cell's secretory and endocytic pathways, responsible for ensuring the precise fusion of transport vesicles with their target membranes. Inhibition of Ykt6p function disrupts these fusion events, resulting in significant alterations to intracellular trafficking and vesicle transport.
v-SNARE Ykt6p inhibitors typically consists of small molecules designed to specifically bind to and inhibit the activity of the Ykt6p protein. These inhibitors work by disrupting the formation of the SNARE complex, a critical step in vesicle fusion. By preventing the Ykt6p protein from participating in the SNARE complex assembly, these inhibitors hinder the fusion of vesicles with their target membranes, thereby impacting processes such as exocytosis, endocytosis, and membrane recycling. This disruption in intracellular trafficking can have profound effects on various cellular functions, including protein secretion, membrane recycling, and organelle maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | $72.00 | ||
Interferes with the formation of SNARE complexes by modifying cysteine residues on Ykt6p, affecting its ability to mediate vesicle fusion. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
Alkylates thiol groups on cysteine residues within Ykt6p, preventing SNARE complex formation. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, indirectly affecting vesicle scission and potentially reducing the availability of vesicles for Ykt6p to act upon. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi structure, indirectly affecting the trafficking pathways that Ykt6p is involved in. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Disrupts Golgi pH gradient, indirectly affecting the trafficking pathways that Ykt6p is involved in. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, indirectly affecting vesicle transport that Ykt6p mediates. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Inhibits actin polymerization, indirectly affecting cytoskeletal dynamics involved in vesicle movement where Ykt6p operates. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin, preventing microtubule polymerization, indirectly affecting vesicle transport that Ykt6p mediates. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Binds tubulin, disrupting microtubule assembly, indirectly affecting vesicle transport that Ykt6p mediates. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects inositol monophosphatase and disrupts phosphoinositide signaling, indirectly affecting membrane trafficking and vesicle fusion where Ykt6p is involved. | ||||||